V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008445 | 220003390 | null | null | null | 2013-04-17 | 2013-04-21 | RAVVA TRIAL | N | N | 220034533 | RAVVA TRIAL |
| 220008446 | 220003390 | 1.68 | 75 | Curative (C) | null | 2017-02-27 | Cytarabine High Dose | N | N | 220034533 | CYTARABINE HIGH DOSE |
| 220008447 | 220003390 | 1.67 | 63.8 | Palliative (P) | 2016-11-26 | 2016-12-12 | Carboplatin + Etoposide iv&po | N | N | 220034533 | CARBOPLATIN + ETOPOSIDE |
| 220008448 | 220003390 | 1.65 | null | Disease modification (D) | 2015-12-13 | 2015-12-13 | GEMCITABINE | 02 | N | 220034533 | PEMBROLIZUMAB |
| 220008449 | 220003391 | 1.64 | 92.6 | Palliative (P) | 2016-09-12 | 2016-09-29 | EOX | N | N | 220034544 | EOX |
| 220008450 | 220011866 | 1.82 | 86.9 | Curative (C) | null | 2017-07-11 | ADE | 02 | N | 220034547 | ADE |
| 220008451 | 220011866 | 1.7 | 70 | Curative (C) | null | 2016-01-19 | Cisplatin + Radiotherapy | null | null | 220034547 | CISPLATIN + RT |
| 220008452 | 220011866 | null | 63.2 | Curative (C) | 2015-08-21 | 2015-08-21 | AML Int Guide ADE 10+3+5 (1) | 02 | N | 220034547 | ADE |
| 220008453 | 220003392 | null | 95 | Not known (9) | null | 2017-03-02 | Cytarabine High Dose | 99 | N | 220034556 | CYTARABINE HIGH DOSE |
| 220008455 | 220003394 | 1.69 | null | Curative (C) | 2013-08-20 | 2013-11-06 | Cytarabine High Dose | N | N | 220034559 | CYTARABINE HIGH DOSE |
| 220008456 | 220003394 | 1.53 | null | Palliative (P) | 2013-07-27 | 2013-08-11 | EOX | N | N | 220034559 | EOX |
| 220008457 | 220003394 | 1.64 | 69.1 | null | 2015-02-22 | 2015-03-21 | Rituximab | N | N | 220034559 | RAVVA TRIAL |
| 220008458 | 220003394 | 1.48 | 77 | Curative (C) | 2015-03-02 | 2015-03-02 | ADE 8+3+5 | 02 | null | 220034559 | ADE |
| 220008459 | 220003394 | 1.78 | 76.6 | Palliative (P) | null | 2014-02-13 | Capecitabine + Oxaliplatin 21day | 02 | N | 220034559 | CAPECITABINE + OXALIPLATIN |
| 220008460 | 220003394 | 0 | 67.9 | Palliative (P) | 2016-07-08 | 2016-07-15 | ECX | N | null | 220034559 | ECX |
| 220008461 | 220003394 | 1.78 | null | Palliative (P) | 2015-11-06 | 2015-11-17 | EOX | N | Y | 220034559 | EOX |
| 220008462 | 220003395 | 1.51 | 66.8 | Curative (C) | 2016-04-29 | 2016-05-11 | PEMBROLIZUMAB | N | N | 220034573 | GEMCITABINE |
| 220008463 | 220003395 | 1.73 | 0 | Palliative (P) | 2018-01-28 | 2018-01-28 | Carboplatin + Etoposide IV 3 day | 02 | N | 220034573 | CARBOPLATIN + ETOPOSIDE |
| 220008464 | 220003395 | 1.67 | 9.2 | Curative (C) | null | 2016-10-28 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034573 | ADE |
| 220008465 | 220003395 | 1.63 | 79.6 | Curative (C) | 2017-05-19 | 2017-05-19 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034573 | ADE |
| 220008468 | 220003397 | 1.77 | 8.5 | Palliative (P) | 2014-11-23 | 2014-12-02 | EOX | N | N | 220034586 | EOX |
| 220008469 | 220003397 | 1.82 | 115.1 | Palliative (P) | 2014-02-11 | 2014-02-18 | Carboplatin AUC 6 - 10 | N | N | 220034586 | CARBOPLATIN |
| 220008470 | 220003398 | 1.74 | 70.4 | Curative (C) | 2015-07-27 | 2015-07-28 | ADE 10+3+5 | N | N | 220034588 | ADE |
| 220008471 | 220011871 | 1.66 | null | Palliative (P) | 2016-09-06 | 2016-09-18 | EOX | N | N | 220034590 | EOX |
| 220008472 | 220003399 | 1.74 | null | Palliative (P) | 2014-10-11 | 2014-10-12 | Capecitabine + Oxaliplatin 21day | N | null | 220034596 | CAPECITABINE + OXALIPLATIN |
| 220008473 | 220003399 | 1.68 | null | Palliative (P) | null | 2013-12-07 | CARBOPLATIN | 02 | Y | 220034596 | CARBOPLATIN |
| 220008474 | 220003399 | 1.57 | 69.4 | Palliative (P) | 2016-05-19 | 2016-05-19 | Gemcitabine weekly | N | N | 220034596 | PEMBROLIZUMAB |
| 220008475 | 220003400 | 1.64 | 56.8 | Palliative (P) | 2013-10-14 | 2013-11-02 | Capecitabine + Oxaliplatin 21day | N | N | 220034600 | CAPECITABINE + OXALIPLATIN |
| 220008476 | 220003401 | null | 66.3 | Palliative (P) | 2013-04-30 | 2013-04-30 | ECX | N | N | 220034601 | ECX |
| 220008477 | 220003402 | 1.72 | null | Palliative (P) | 2017-03-14 | 2017-03-28 | Carboplatin + Etoposide iv&po | N | N | 220034603 | CARBOPLATIN + ETOPOSIDE |
| 220008478 | 220003403 | 1.69 | 75 | Palliative (P) | 2015-05-10 | 2015-05-10 | GEMCITABINE | 02 | N | 220034604 | GEMCITABINE |
| 220008479 | 220003404 | null | 69 | null | null | 2015-05-26 | FLUOROURACIL + OXALIPLATIN | 99 | null | 220034605 | OXALIPLATIN + MDG |
| 220008480 | 220003404 | 1.8 | 96.6 | null | 2014-07-08 | 2014-07-07 | Rituximab | N | N | 220034605 | GEMCITABINE |
| 220008481 | 220003405 | 1.64 | 83 | Palliative (P) | 2015-11-01 | 2015-11-01 | EOX | Y | null | 220034611 | EOX |
| 220008482 | 220003405 | null | 84 | Palliative (P) | 2015-03-13 | 2015-03-13 | ECX | N | null | 220034611 | ECX |
| 220008483 | 220003405 | 1.5 | 12.8 | Palliative (P) | 2017-01-06 | 2017-01-21 | Oxaliplatin + Modified de Gramont | N | N | 220034611 | OXALIPLATIN + MDG |
| 220008484 | 220003406 | 2 | 91.6 | Palliative (P) | 2018-01-22 | 2018-01-27 | Carboplatin AUC 2 - 5 | N | N | 220034615 | CARBOPLATIN |
| 220008485 | 220003407 | 1.7 | 110.3 | Palliative (P) | 2015-03-27 | 2015-03-27 | Oxaliplatin + Modified de Gramont | N | N | 220034617 | OXALIPLATIN + MDG |
| 220008486 | 220003407 | null | 70 | Palliative (P) | 2016-05-10 | 2016-05-16 | EOX | 02 | N | 220034617 | EOX |
| 220008487 | 220003408 | null | 52 | null | 2016-02-15 | 2016-02-25 | Carboplatin + Etoposide iv&po | 02 | N | 220034620 | CARBOPLATIN + ETOPOSIDE |
| 220008488 | 220003408 | 1.8 | 80.2 | Palliative (P) | 2014-10-20 | 2014-10-20 | Oxaliplatin + Modified de Gramont | N | N | 220034620 | OXALIPLATIN + MDG |
| 220008489 | 220003408 | null | 88.6 | Curative (C) | 2013-04-18 | 2013-04-24 | AML Int Guide ADE 10+3+5 (1) | null | null | 220034620 | ADE |
| 220008490 | 220003408 | 1.6 | 60 | Curative (C) | 2015-03-15 | 2015-03-15 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034620 | ADE |
| 220008491 | 220003408 | null | 81 | Curative (C) | null | 2014-01-01 | Cytarabine High Dose | 02 | null | 220034620 | CYTARABINE HIGH DOSE |
| 220008492 | 220003409 | 1.73 | null | Palliative (P) | 2015-07-02 | 2015-07-10 | Capecitabine + Oxaliplatin 21day | N | N | 220034632 | CAPECITABINE + OXALIPLATIN |
| 220008493 | 220011877 | 0 | null | Curative (C) | 2016-09-20 | 2016-09-20 | ADE | 02 | Y | 220034633 | ADE |
| 220008494 | 220003410 | null | 90.5 | Curative (C) | null | 2016-06-17 | AML Int Guide ADE 10+3+5 (1) | null | null | 220034635 | ADE |
| 220008495 | 220003411 | 1.73 | 62.4 | Curative (C) | 2016-04-03 | 2016-04-03 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | 220034639 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008496 | 220003411 | 1.64 | 77.6 | Palliative (P) | 2016-07-24 | 2016-07-24 | CARBOPLATIN | 02 | N | 220034639 | CARBOPLATIN |
| 220008497 | 220003411 | 1.65 | 88.5 | Palliative (P) | 2016-05-25 | 2016-05-25 | RAVVA TRIAL | N | N | 220034639 | RITUXIMAB |